Cite
Shafiq N, Rajagopalan S, Kushwaha HN, et al. Single Ascending Dose Safety and Pharmacokinetics of CDRI-97/78: First-in-Human Study of a Novel Antimalarial Drug. Malar Res Treat. 2014;2014:372521doi: 10.1155/2014/372521.
Shafiq, N., Rajagopalan, S., Kushwaha, H. N., Mittal, N., Chandurkar, N., Bhalla, A., Kaur, S., Pandhi, P., Puri, G. D., Achuthan, S., Pareek, A., Singh, S. K., Srivastava, J. S., Gaur, S. P., & Malhotra, S. (2014). Single Ascending Dose Safety and Pharmacokinetics of CDRI-97/78: First-in-Human Study of a Novel Antimalarial Drug. Malaria research and treatment, 2014372521. https://doi.org/10.1155/2014/372521
Shafiq, N, et al. "Single Ascending Dose Safety and Pharmacokinetics of CDRI-97/78: First-in-Human Study of a Novel Antimalarial Drug." Malaria research and treatment vol. 2014 (2014): 372521. doi: https://doi.org/10.1155/2014/372521
Shafiq N, Rajagopalan S, Kushwaha HN, Mittal N, Chandurkar N, Bhalla A, Kaur S, Pandhi P, Puri GD, Achuthan S, Pareek A, Singh SK, Srivastava JS, Gaur SP, Malhotra S. Single Ascending Dose Safety and Pharmacokinetics of CDRI-97/78: First-in-Human Study of a Novel Antimalarial Drug. Malar Res Treat. 2014;2014:372521. doi: 10.1155/2014/372521. Epub 2014 Mar 27. PMID: 24800100; PMCID: PMC3985299.
Copy
Download .nbib